Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/31/2002US20020161213 Novel human kinases and polynucleotides encoding the same
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161211 Compositions, methods and kits relating to REMODELIN
10/31/2002US20020161209 For therapy of disease that is associated with an RNA molecule
10/31/2002US20020161204 Methods of detecting a liver disorder
10/31/2002US20020161202 For modulating apoptosis in mammalian cells
10/31/2002US20020161201 For use in cancer diagnosis and therapy
10/31/2002US20020161200 For therapy
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002US20020161192 Helicobacter pylori live vaccine
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020161190 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability
10/31/2002US20020161178 Novel DKR polypeptides
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020160980 Method of treating hepatitis delta virus infection
10/31/2002US20020160977 Method for selective inactivation of viral replication
10/31/2002US20020160976 Method for selective inactivation of viral replication
10/31/2002US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
10/31/2002US20020160971 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor
10/31/2002US20020160970 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/31/2002US20020160969 Nucleosides and oligonucleotides containing boron clusters
10/31/2002US20020160959 Therapeutic compounds for ovarian cancer
10/31/2002US20020160957 Treating tumors
10/31/2002US20020160955 Protein variants
10/31/2002US20020160954 Polynucleotides; Interphotoreceptor matrix component (IPMC) gene family; treating eye disorders
10/31/2002US20020160941 Treating compositions with lactoferrin
10/31/2002US20020160940 Modulation of endogenous gene expression in cells
10/31/2002US20020160933 Methods and compositions for producing a neurosalutary effect in a subject
10/31/2002US20020160915 Altering the ATP gradient across the membrane of a target cell by inhibiting an extracellular phosphatase (ecto-phosphatase) in the target cell
10/31/2002US20020160516 Useful to the pharmaceutical and biotechnology industries
10/31/2002US20020160515 Formation of polyampholytes in the presence of a polyion
10/31/2002US20020160514 Expression vector system and a method for optimization and confirmation of DNA delivery and quantification of targeting frequency
10/31/2002US20020160509 For use in transplantation or drug screening and drug discovery in vitro
10/31/2002US20020160507 For expressing an inserted protein coding DNA sequence
10/31/2002US20020160502 For use in immunotherapy
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002US20020160500 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160498 Can be used, for example, as target molecules for developing drugs against cancer
10/31/2002US20020160494 Tendon-inducing compositions
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160491 For diagnosis, prophylaxis and therapy of cancer, inflammation, neurological disorders and immune diseases and/or disorders
10/31/2002US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002US20020160485 Polynucleotide motor, a motor system, their preparation and uses
10/31/2002US20020160484 Central nervous system disorders therapy; genetic engineering
10/31/2002US20020160482 Genetic engineering; fusion proteins; transfection, culture product; immobilization
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160477 CAF1-related protein
10/31/2002US20020160476 Genetic engineeering; binding to antibodies
10/31/2002US20020160475 Novel human ion channel protein and polynucleotides encoding the same
10/31/2002US20020160474 Adipocyte complement related protein zacrp11
10/31/2002US20020160473 Far red shifted fluorescent proteins
10/31/2002US20020160472 Coupling drug to glycidyl methacrylate-styrene copolymer
10/31/2002US20020160468 Using nicotinamide-adenine dinucleotide coenzyme
10/31/2002US20020160466 Form nitrile in aqueous solution
10/31/2002US20020160463 Phagemid for antibody screening
10/31/2002US20020160462 Polymerase chain reactions
10/31/2002US20020160461 Method for producing substance utilizing microorganism
10/31/2002US20020160460 Practical in vitro sialylation of recombinant glycoproteins
10/31/2002US20020160459 Process for production of n-glucosamine
10/31/2002US20020160458 Gene expression of endoprotease in eukaryotic cells; yeast culture product
10/31/2002US20020160457 Immobilizated antigens; cloning gene sequence; electroporation; calibration
10/31/2002US20020160455 Methods and host cells for improved cell culture
10/31/2002US20020160454 Biosynthesis of polynucleotides using amplification primers
10/31/2002US20020160453 Novel gene encoding a sodium channel beta-3 subunit protein
10/31/2002US20020160451 Isolated nucleic acids; genetic engineering
10/31/2002US20020160450 Methods and compositions for increasing protein yield from a cell culture
10/31/2002US20020160449 Human vomeronasal receptor
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160438 Modulate kinase; antiinflammatory agents; respiratory system disorders
10/31/2002US20020160437 Insertion exogeneous material into cell; drug screening
10/31/2002US20020160433 Diagnosis of urogenital disorders
10/31/2002US20020160415 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for the prevention of cancer in at- risk subjects
10/31/2002US20020160410 Amplification of nucleic acids
10/31/2002US20020160409 Hybrid chromosome detector; cancer detection
10/31/2002US20020160408 Detection interaction between proteins
10/31/2002US20020160404 Tumor diagnosis
10/31/2002US20020160402 Linear and circular expression elements
10/31/2002US20020160399 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
10/31/2002US20020160397 Measuring variations; calibration
10/31/2002US20020160396 Labeling with organoplatinum compound
10/31/2002US20020160393 Controlling gene expression in eukaryotic cells
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160390 Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
10/31/2002US20020160389 Polymerase chain reactions; screening
10/31/2002US20020160388 Compositions and methods relating to lung specific genes and proteins
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures
10/31/2002US20020160380 Combinatorial libraries by recombination in yeast and analysis method
10/31/2002US20020160379 Gapped 2' modified oligonucleotides
10/31/2002US20020160378 Detection hybrids; cell differentiation; gene expression;
10/31/2002US20020160377 In situ translation; generating fusion proteins; libraries
10/31/2002US20020160375 Generating tissue; cell differentiation
10/31/2002US20020160371 56739, a novel CUB domain containing protein and uses thereof
10/31/2002US20020160366 Cloning; separation, denaturing, hybridization
10/31/2002US20020160362 Measurement variations of allele polypeptides gene; diagnosis of arthritis, cancer
1 ... 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 ... 4023